https://www.selleckchem.com/pr....oducts/aticaprant.ht
Insomnia severity did not change by 4-h TRF (baseline 4.4 ± 1.0; week 8 4.7 ± 0.9) or 6-h TRF (baseline 8.3 ± 1.2; week 8 5.5 ± 1.1), versus controls. Percent of participants reporting obstructive sleep apnea symptoms did not change by 4-h TRF (baseline 44%; week 8 25%) or 6-h TRF (baseline 47%; week 8 20%), versus controls. These findings suggest that 4- and 6-h TRF have no effect on sleep quality, duration, insomnia severity, or the risk of obstructive sleep apnea. These findings suggest that 4- and 6-h TRF have no effect on sleep
Like
Comment
Share
